Anticancer activity of the bioreductive and non-bioreductive zerumbone derivatives

Letters in Drug Design and Discovery

Volumn 8, Issue 6, 2011, Pages 536-543

  Pitchuanchom, Siripit ^a   Songsiang, Uraiwan ^a   Weerapreeyakul, Natthida ^b   Yenjai, Chavi ^a  

^a Khon Kaen University   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Bioreductive; KB; MCF 7; NCI H187; Zerumbone derivatives; Zingiber zerumbet Smith

Indexed keywords

13 BROMO 2,9,9 TRIMETHYLCYCLOUNDECA 2,6,10 TRIENONE; 13 HYDROXY 2,9,9 TRIMETHYLCYCLOUNDECA 2,6,10 TRIENONE; 3 AMINO 2,6,9,9 TETRAMETHYLCYCLOUNDECA 6,10 DIENONE; 6 HYDROXY 4,4,5,7,8 PENTAMETHYLHYDROCOUMARIN; ANTINEOPLASTIC AGENT; BETA,BETA,2,4,5 PENTAMETHYL 3,6 DIOXO 1,4 CYCLOHEXADIENE 1 PROPANOIC ACID; UNCLASSIFIED DRUG; ZERUMBONAMINONE; ZERUMBONE DERIVATIVE; ZERUMBONOQUINONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL STRAIN KB; CELL STRAIN MCF 7; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; TOXICITY TESTING; VERO CELL;

EID: 79959343268     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018011795906811     Document Type: Article

References (20)

1. Abdul, A.B.; Abdelwahab, S.I.; Al-Zubairi, A.S.; Elhassan, M.M.; Murali, S.M. Anticancer and antimicrobial activities of zerumbone from the rhizomes of Zingiber zerumbut. Int. J. Pharmacol., 2008, 4, 301-304.
2. Alwi, S.S.S.; Nallappan, M.; Pihie, A.H.L. Zerumbone exerts antiproliferative activity via apoptosis on HepG2 cells. Malaysian J. Biochem., Mol. Biol. 2007, 15, 19-23.
3. Murakami, A.; Takahashi, D.; Kinoshita, T.; Koshimizu, K.; Kim, H.W.; Yoshihiro, A.; Nakamura, Y.; Jiwajinda, S.; Terao, J.; Ohigashi, H. Zerumbone, a southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: The α,β-unsaturated carbonyl group is a prerequisite. Carcinogenesis, 2002, 23, 795-802. (Pubitemid 34567518)
4. Xian, M.; Ito, K.; Nakazato, T.; Shimizu, T.; Chen, C.K.; Yamato, K.; Murakami, A.; Ohigashi, H.; Ikeda, Y.; Kizaki, M. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway. Cancer Science, 2007, 98, 118-126. (Pubitemid 44803930)
5. Dai, J.R.; Cardellina, J.H.; McMahon, J.B.; Boyd, M.R. Zerumbone, an HIV-inhibitory and cytotoxic sesquiterpene of Zingiber aromaticum and Z. zerumbet. Nat. Prod. Lett., 1997, 10, 115-118. (Pubitemid 27292336)
6. Kitayama, T.; Yokoi, T.; Kawai, Y.; Hill, R.K.; Morita, M.; Okamoto, T.; Yamamoto, Y.; Fokin, V.V.; Sharpless, K.B.; Sawada, S. The chemistry of zerumbone. Part 5: Structural transformation of the dimethylamine derivatives. Tetrahedron, 2003, 59, 4857-4866. (Pubitemid 36695135)
7. Songsiang, U.; Pitchuanchom, S.; Boonyarat, C.; Hahnvajanawong, C.; Yenjai, C. Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives. Eur. J Med. Chem., 2010, 45, 3794-3802.
8. Gharat, L.; Visser, P.; Brumelhuis, M.; Guiles, R.; Chikhale, P.J. Reductive activation of conformationally-constrained, anticancer drug delivery systems. Med. Chem. Res., 1998, 8, 444-456. (Pubitemid 29048739)
9. Weerapreeyakul, N.; Visser, P.; Brumelhuis, M.; Gharat, L.; Chikhale, P.J. Reductive and bioreductive activation is controlled by electronic properties of substituents in conformationallyconstrained anticancer drug delivery systems. Med. Chem. Res., 2000, 10, 149-163. (Pubitemid 32014482)
10. Weerapreyakul, N.; Anorach, R.; Khuansawad, T.; Yenjai, C.; Isaka, M. Synthesis of bioreductive esters from fungal compounds. Chem. Pharm. Bull., 2007, 55, 930-935. (Pubitemid 46890099)
11. Cheu, Y.; and Hu, L. Design of anticancer prodrugs for reductive activation. Med. Res. Rev., 2009, 29, 29-64.
12. Begleitera, A.; Leitha, M.K.; Dohertya, G.P.; Digbya, T.J.; Pan, S. Factors influencing the induction of DT-diaphorase activity by 1,2- dithiole-3-thione in human tumor cell lines. Biochem. Pharmacol., 2001, 61, 955-964. (Pubitemid 32247384)
13. Siegel, D.; Ross, D. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radical Biol. Med., 2000, 29, 246-253.
14. Wang, X.; Doherty, G.P.; Leith, M.K.; Curphey, T.J.; Begleiter, A. Enhanced cytotoxicity of mitomycin C in human tumor cells with inducers of DT-diaphorase. Br. J. Cancer, 1999, 80, 1223-1230. (Pubitemid 29264083)
15. Carpino, L.A.; Triolo, S.A.; Berglund, R.A. Reductive lactonization of strategically methylated quinone propionic acid esters and amides. J. Org. Chem., 1989, 54, 3303-3310.
16. Nicolaou, M.G.; Yuan, C.S.; Borchardt, R.T. Phosphate prodrugs for amines utilizing a fast intramolecular hydroxy amide lactonization. J. Org. Chem., 1996, 61, 8636-8641. (Pubitemid 26419372)
17. Rosetti, M.; Frasnelli, M.; Fabbri, F.; Arienti, C.; Vannini, I.; Tesei, A.; Zoli, W.; Conti, M. Pro-apoptotic activity of cyclopentenone in cancer cells. Anticancer Res., 2008, 28, 315-320. (Pubitemid 351362919)
18. Levine M.N.; Lavis L.D.; Raines R.T. Trimethyl lock: a stable chromogenic substrate for esterases. Molecules. 2008, 13, 204-211.
19. Brien, J.O.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem., 2000, 267, 5421-5426.
20. Hunt, L.; Jordan, M.; De Jesus, M.; Wurm, F.M.; GFP-expressing mammalian cells for fast sensitive, noninvasive cell growth assessment in a kinetic mode. Biotechnol. and Bioeng., 1999, 65, 201-205. (Pubitemid 29441456)